其他
免疫检查点抑制剂能否在驱动基因融合突变的NSCLC治疗中占据一席之地
1. Leone Gianmarco, Passiglia Francesco, BironzoPaolo et al. Is there any place for immune-checkpoint inhibitors in thetreatment algorithm of fusion-driven non-small cell lung cancer?-a literaturereview. Transl Lung Cancer Res, 2020, 9: 2674-2685.
精彩推荐:
- End -